Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5455-5459

  Yavuzcan, Ali ^a   Caglar, Mete ^a   Ozgu, Emre ^b   Ustun, Yusuf ^a   Dilbaz, Serdar ^a   Ozdemir, Ismail ^c   Yildiz, Elif ^a   Gungor, Tayfun ^b   Kumru, Selahattin ^a  

^a DUZCE UNIVERSITY   (Turkey)

^b ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c Medicana International Istanbul   (Turkey)

Author keywords

Adnexal mass; Ovarian cancer; Risk of malignancy index

Indexed keywords

CA 125 ANTIGEN;

ADNEXA DISEASE; ARTICLE; ASIA; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; OVARY TUMOR; PACIFIC ISLANDS; PREDICTIVE VALUE; PREGNANCY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADNEXAL DISEASES; ASIA; CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACIFIC ISLANDS; PREDICTIVE VALUE OF TESTS; PREGNANCY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84887603121     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5455     Document Type: Article

References (23)

1. Aktürk E, Karaca RE, Alanbay I, et al (2011). Comparison of four malignancy risk indices in the detection of malignant ovarian masses. J Gynecol Oncol, 22, 177-82.
2. Alcázar JL, Pascual MA, Olartecoechea B, et al (2013). IOTA simple rules for discriminating between benign and malignant adnexal masses: a prospective external validation. Ultrasound Obstet Gynecol, 42, 467-71.
3. Andersen ES, Knudsen A, Rix P, Johansen B (2003). Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol, 90, 109-12.
4. Ashrafgangooei T, Rezaeezadeh M (2011). Risk of malignancy index in preoperative evaluation of pelvic masses. Asian Pac J Cancer Prev, 12, 1727-30.
5. Bailey J, Tailor A, Naik R, et al (2006). Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?. Int J Gynecol Cancer, 16, 30-4.
6. rd, Ngan HY, Pecorelli S (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obstet, 70, 209-62.
7. Benjapibal M, Neungton C (2007). Pre-operative prediction of serum CA 125 level in women with ovarian masses. J MedAssoc Thai, 90, 1986-91.
8. Bouzari Z, Yazdani S, Ahmadi MH, et al (2011). Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses. BMC Res Notes, 4, 206.
9. Cure MC, Cure E, Kirbas A, Yazici T, Yuce S (2012). Requests for tumor marker tests in Turkey without indications and frequency of elevation in benign conditions. Asian Pac J Cancer Prev, 13, 6485-9.
10. Dehaghani AS, Ghiam AF, Hosseini M, Mansouri S, Ghaderi A (2007). Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women. Pathol Oncol Res, 13, 360-4.
11. Gultekin M, Dursun P, Dogan NU, et al (2009). Debulking surgery for incompletely operated advanced epithelial ovarian carcinoma. J Surg Oncol, 100, 258-60.
12. Hafeez S, Sufian S, Beg M, et al (2013). Role of ultrasound in characterization of ovarian masses. Asian Pac J Cancer Prev, 14, 603-6.
13. Harlan LC, Clegg LX, Trimble EL (2003). Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol, 21, 3488-94.
14. Jacobs I, Oram D, Fairbanks J, et al (1990) A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol, 97, 922-9.
15. Khattak YJ, Hafeez S, Alam T, et al (2013). Ovarian masses: is multi-detector computed tomography a reliable imaging modality? Asian Pac J Cancer Prev, 14, 2627-30.
16. Lou HY, Meng H, Zhu QL, Zhang Q, Jiang YX (2010). Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 32, 297-302.
17. Moolthiya W, Yuenyao P (2009). The risk of malignancy index (RMI) in diagnosis of ovarian malignancy. Asian Pac J Cancer Prev, 10, 865-8.
18. Ong C, Biswas A, Choolani M, Low JJ (2013). Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population. Singapore Med J, 54, 136-9.
19. Tingulstad S, Hagen B, Skjeldestad FE, et al (1999). The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol, 93, 448-52.
20. Tingulstad S, Hagen B, Skjeldestad FE, et al (1996). Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol, 103, 826-31.
21. van den Akker PA, Zusterzeel PL, Aalders AL, et al (2011). External validation of the adapted risk of malignancy index incorporating tumor size in the preoperative evaluation of adnexal masses. Eur J Obstet Gynecol Reprod Biol, 159, 422-5.
22. Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T (2009). Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol, 144, 163-7.
23. Zalel Y, Tepper R, Altaras M, et al (1996). Transvaginal sonographic measurements of postmenopausal ovarian volumes as a possible detection of ovarian neoplasia. Acta Obstet Gynecol Scand, 75, 668-71.